Navigation Links
China Medicine to Showcase 'Bethin' Weight Loss Product at 2008 Natural Products Expo East Trade Show

GUANGZHOU, China, Oct. 13 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME; "China Medicine" or "the Company"), a leading distributor and developer of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines ("TCM"), nutritional and dietary supplements, medical devices, and medical formulations in the People's Republic of China ("PRC"), through its wholly-owned U.S subsidiary, Konzern U.S Holding Corporation, announced today that it will participate in the 2008 Natural Products Expo East tradeshow, where it will showcase its new weight loss product called "Bethin." The tradeshow will be held Oct. 15th to Oct. 18th at the Boston Convention & Exhibition Center in Massachusetts. Over 25,000 natural, organic, and health products industry members will participate in this event.

China Medicine's proprietary weight loss product, Bethin, is a food supplement that is designed to promote and adjust fat metabolism, reduce the storage of fat in the body, and prolong endurance during physical exercise. Bethin's active ingredients include L-Carnitine, a special amino acid manufactured by the human body that is essential for the production of energy, and Hydroxycitric acid (HCA), an extract from the fruit of the Garcinia cambogia plant. The Company has filed and obtained all the necessary documentation to launch the new product in the United States.

"We are looking forward to taking part in the upcoming Natural Products Expo East tradeshow in Boston," said Mr. Senshan Yang, Chairman and CEO of China Medicine. "We anticipate that the introduction of Bethin, our first product sold in U. S. market, will increase our visibility, highlight the benefits of our new product, and allow us to gain a foothold in the international market."

The Company will be exhibiting its product in booth #240. For more information on the tradeshow, please click .

About China Medicine Corporation

China Medicine Corporation is a leading pharmaceutical company which discovers and develops medical formulations and distributes over 2,200 pharmaceutical products in China including prescription and over the counter ("OTC") drugs, traditional Chinese medicine products, herbs and dietary-supplements. The Company distributes the products to wholesale distributors in 28 provinces, more than 300 hospitals, 500 medicine companies, and 1,788 drug stores throughout China. The Company actively develops a number of proprietary products for many uses including oncology, high blood pressure and the removal of toxins from food and animal feed. For more information visit the Company's website at .

Cautionary Statement

This press release contains forward-looking statements concerning the Company's business and products. The Company's actual results may differ materially depending on a number of risk factors including, but not limited to, the following: general economic and business conditions, obtaining regulatory approval for new products, the expected contribution of higher margin products, government support for rural health care, competition from existing and new competitors, changes in technology, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risk factors detailed in the Company's reports filed with the Securities and Exchange Commission. China Medicine Corporation undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.

For further information, please contact:

China Medicine Corp

Ms. Huizhen Yu


Tel: +86-20-8739-1718


Mr. Crocker Coulson


CCG InvestorRelations Inc.

Tel: +1-646-213-1915


SOURCE China Medicine Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China Yingxia International, Inc. Announces $2 Million Share Repurchase Program
2. China Biologic Products Enters Into Agreement to Acquire 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.
3. WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
4. Covance Decides to Pursue Its Original Preclinical Strategy in China
5. China Sky One Medical, Inc. Raises Guidance for 2008 Revenue and Net Income
6. China-Biotics, Inc. Announces Results of 2008 Annual General Meeting of Shareholders
7. Chinas Farmers Welcome the New Trend of Organic Farming
8. China Sky One Medical, Inc. Passes First Phase Examination for (CE) Certification
9. China Pharma Holdings, Inc. Projects 3rd Quarter 2008 Revenue Growth to Exceed 40%
10. China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII
11. China Biopharma Effects 1 for 100 Reverse Stock Split
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... ... the year and one of the premier annual events for pharmaceutical manufacturing: 2015 ... 8–11 November 2015, where ISPE hosted the largest number of attendees in more ...
(Date:11/24/2015)... 24, 2015  Clintrax Global, Inc., a worldwide provider of clinical ... today announced that the company has set a new quarterly earnings ... on quarter growth posted for Q3 of 2014 to Q3 of ... Mexico , with the establishment of an ... --> United Kingdom and Mexico ...
(Date:11/24/2015)... ... ... This fall, global software solutions leader SAP and AdVenture Capital brought together ... their BIG ideas to improve health and wellness in their schools. , Now, the ... title of SAP's Teen Innovator, an all-expenses paid trip to Super Bowl 50, and ...
(Date:11/24/2015)... Massachusetts , November 24, 2015 SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ... , Chief Financial Officer, will participate in the Piper Jaffray 27 ... , NY on Tuesday, December 1, 2015, at 8:30 a.m. ...
Breaking Biology Technology:
(Date:11/18/2015)... , November 18, 2015 ... has published a new market report titled  Gesture Recognition ... and Forecast, 2015 - 2021. According to the report, the global ... and is anticipated to reach US$29.1 bn by 2021, ... North America dominated the ...
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
Breaking Biology News(10 mins):